Serum S-100β as a possible marker of blood–brain barrier disruption
2002; Elsevier BV; Volume: 940; Issue: 1-2 Linguagem: Inglês
10.1016/s0006-8993(02)02586-6
ISSN1872-6240
AutoresMiranda Kapural, Lj Krizanac-Bengez, Gene H. Barnett, John Perl, T. Masaryk, D Apollo, Peter A. Rasmussen, Marc R. Mayberg, Damir Janigro,
Tópico(s)Acute Ischemic Stroke Management
ResumoTwo brain-specific proteins, S-100β and neuron-specific enolase (NSE), are released systemically after cerebral lesions, but S-100β levels sometimes rise in the absence of neuronal damage. We hypothesized that S-100β is a marker of blood–brain barrier (BBB) leakage rather than of neuronal damage. We measured both proteins in the plasma of patients undergoing iatrogenic BBB disruption with mannitol, followed by chemotherapy. Serum S-100β increased significantly after mannitol infusion (P<0.05) while NSE did not. This suggests that S-100β is an early marker of BBB opening that is not necessarily related to neuronal damage.
Referência(s)